Dominique Valla

Liver fibrosis is not associated with steatosis but with necroinflammation in French patients with chronic hepatitis C

F. Tubach, T. Asselah, P. Marcellin, 2003, Gut.

Second infection with a different hepatitis C virus genotype in a intravenous drug user during interferon therapy

D. Vidaud, N. Boyer, M. Martinot, 2003, Gut.

Hepatocellular carcinoma in Budd–Chiari syndrome: characteristics and risk factors

V. Vilgrain, D. Valla, J. Belghiti, 2008, Gut.

Insulin resistance and geographical origin: major predictors of liver fibrosis and response to peginterferon and ribavirin in HCV-4

P. Marcellin, M. Vidaud, D. Valla, 2009, Gut.

Sequential therapy with adefovir dipivoxil and pegylated Interferon Alfa‐2a for HBeAg‐negative patients

P. Marcellin, N. Boyer, R. Moucari, 2011, Journal of viral hepatitis.

Kinetics of serum cytokines reflect changes in the severity of chronic hepatitis C presenting minimal fibrosis

T. Asselah, P. Marcellin, D. Valla, 2002, Journal of viral hepatitis.

Hypervariable region 1 quasispecies in hepatitis C virus genotypes 1b and 3 infected patients with normal and abnormal alanine aminotransferase levels

T. Asselah, P. Marcellin, D. Valla, 2002, Journal of viral hepatitis.